To assess the gene expression profiles of B lymphocytes that migrated through the choroid plexus epithelium, total CD19+ B cells obtained from ten MS patients with clinically active disease and 15 normal donors were tested in TM assays against a mix of CXCL12 and CXCL13. This evidence concerns the gene CD19 and myeloid sarcoma.